NCT04301258

Brief Summary

The primary objective of this registry is to obtain long-term outcomes on ProChondrix CR in cartilage repair procedures of the knee, ankle, foot and hip.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2020

Typical duration for all trials

Geographic Reach
1 country

5 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 10, 2020

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2023

Completed
Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

3.7 years

First QC Date

March 6, 2020

Last Update Submit

November 20, 2025

Conditions

Keywords

CartilageCartilage InjuryCartilage RepairCartilage DamageCartilage LesionCartilage Defect

Outcome Measures

Primary Outcomes (1)

  • Long-Term Outcomes of ProChondrix CR

    Obtain long-term results on patients who have undergone an articular cartilage repair procedure using ProChondrix CR, as assessed by patient reported outcomes.

    10 Years Post-Operative

Study Arms (4)

Articular Cartilage Defect of the Knee

Patients, who undergo an articular cartilage repair of the knee using ProChondrix CR.

Other: Articular cartilage repair

Articular Cartilage Defect of the Ankle

Patients, who undergo an articular cartilage repair of the ankle using ProChondrix CR.

Other: Articular cartilage repair

Articular Cartilage Defect of the Foot

Patients, who undergo an articular cartilage repair of the foot using ProChondrix CR.

Other: Articular cartilage repair

Articular Cartilage Defect of the Hip

Patients, who undergo an articular cartilage repair of the hip using ProChondrix CR.

Other: Articular cartilage repair

Interventions

Patient reported outcomes will be collected on patients who have had a cartilage repair procedure using ProChondrix CR in the knee, hip, foot or ankle.

Also known as: ProChondrix CR
Articular Cartilage Defect of the AnkleArticular Cartilage Defect of the FootArticular Cartilage Defect of the HipArticular Cartilage Defect of the Knee

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients, who diagnosed by their treating physician, have a cartilage defect in the knee, ankle, foot or hip that requires surgical intervention utilizing ProChondrix CR.

You may qualify if:

  • Diagnosed by physician to have a cartilage defect in the knee, ankle, foot or hip that requires surgical intervention;
  • Will be having, or has had, a cartilage repair procedure using ProChondrix CR;
  • Has the ability to understand the requirements of the registry, to provide written informed consent and to comply with the registry protocol;

You may not qualify if:

  • Is a ward of the state, prisoner, or transient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

University of Southern Alabama

Mobile, Alabama, 36604, United States

Location

Rocky Mountain Foot and Ankle Center

Wheat Ridge, Colorado, 80033, United States

Location

CAO Research Foundation

Washington D.C., District of Columbia, 20037, United States

Location

University of Kentucky Research Foundation

Lexington, Kentucky, 40506, United States

Location

Beacon Orthopaedics & Sports Medicine

Cincinnati, Ohio, 45247, United States

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
10 Years
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2020

First Posted

March 10, 2020

Study Start

January 6, 2020

Primary Completion

September 14, 2023

Study Completion

September 14, 2023

Last Updated

November 21, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations